Company profile: GeneTether
1.1 - Company Overview
Company description
- Provider of genome editing enhancement platforms that tether or conjugate donor DNA templates to editing complexes, including the GeneTether Platform and TNT technology to boost DNA insertion efficiency with targeted tools like CRISPR-Cas, and pursuing strategic partnerships in human therapeutics, animal health, agriculture, and cell delivery.
Products and services
- DNA Template-Nuclease Tethering (TNT™) Platform: A conjugation-based technology that increases editing efficiency by tethering donor DNA templates to targeted genome editing technologies like CRISPR-Cas to improve precise insertion outcomes
- GeneTether Platform: A tethering-based platform that enhances the efficiency of DNA insertion into the genome by linking donor DNA templates directly to genome editing complexes for more effective delivery
- Strategic Partnerships and Collaborations: Application-specific alliances in human therapeutics, animal health, agriculture, and cell delivery to advance platform applications and broaden genome editing with donor DNA template tethering
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to GeneTether
Organ-i
HQ: United States
Website
- Description: Provider of novel biotech diagnostic tests for renal diseases, improving clinicians’ ability to monitor the health of transplanted kidneys and providing valuable treatment information for patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Organ-i company profile →
LogicBio Therapeutics
HQ: United States
Website
- Description: Provider of gene therapy vectors for previously incurable genetic and infectious diseases, committed to delivering genetic medicine to pediatric patients with rare diseases. Utilizes proprietary technology based on a non-pathogenic adeno-associated viral vector, offering superior efficiency and safety compared to competitors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LogicBio Therapeutics company profile →
Fabric Genomics
HQ: United States
Website
- Description: Provider of genomics-driven precision medicine software, delivering end-to-end genomic analysis, interpretation, and clinical reporting for clinical labs, hospital systems, and country-sequencing programs. Powers actionable genomic insights to enable faster, more accurate diagnoses, featuring AI algorithms including GEM, VAAST, and Phevor for disease gene and phenotype-driven variant ranking.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fabric Genomics company profile →
Inari
HQ: United States
Website
- Description: Provider of seed design and biotechnology focused on developing seeds for a nature-positive food system, leveraging predictive design and multiplex gene editing to transform agriculture and its impact on society and the environment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inari company profile →
Iveric Bio
HQ: United States
Website
- Description: Provider of science-driven biopharmaceutical research and development focused on novel treatment options for retinal diseases with significant unmet medical needs, including age-related macular degeneration, developing therapeutic product candidates for age-related retinal diseases and gene therapy product candidates.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Iveric Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for GeneTether
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to GeneTether
2.2 - Growth funds investing in similar companies to GeneTether
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for GeneTether
4.2 - Public trading comparable groups for GeneTether
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →